By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120


Key Statistics

Ownership: Public

Web Site: Cellectar Biosciences
Symbol: CLRB


Drug Discovery

Company News
Cellectar Biosciences  (CLRB) Announces New Positive Data From Phase I Clinical Study Of CLR 131 In Multiple Myeloma 9/29/2016 11:31:20 AM
Cellectar Biosciences  (CLRB) To Present At OktoberINVESTfest 9/21/2016 10:32:24 AM
Cellectar Biosciences  (CLRB) Announces Lead Compound CLR 131 To Be Studied In Head And Neck Cancer In $12 Million University of Wisconsin SPORE Grant 9/12/2016 8:04:34 AM
Cellectar Biosciences  (CLRB) To Present At The 18th Annual Rodman & Renshaw Global Investment Conference 9/6/2016 10:21:15 AM
Cellectar Biosciences  (CLRB) To Host Conference Call On August 15 To Report Second Quarter 2016 Financial Results And Corporate Performance 8/8/2016 8:21:54 AM
Cellectar Biosciences  (CLRB) Announces $2 Million NCI SBIR Contract For A Phase II Clinical Study 8/3/2016 8:43:35 AM
Cellectar Biosciences  (CLRB) Appoints Jarrod Longcor Senior Vice President Of Corporate Development And Operations 7/20/2016 8:52:07 AM
Cellectar Biosciences  (CLRB) Announces Results Of NCI-Sponsored Study Of CLR 125 Showing Potential Effect Against Triple Negative Breast Cancer 6/23/2016 7:53:47 AM
Cellectar Biosciences  (CLRB) Announces Positive Data From Phase I Therapeutic Trial Of CLR 131 In Multiple Myeloma 1/5/2016 8:14:22 AM
Cellectar Biosciences  (CLRB) And Pierre Fabre Announce Oncology Research Collaboration 12/16/2015 10:28:47 AM